×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
PMN – promis neurosciences inc. (US:AMEX)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
PMN
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
11/14
09:15 am
pmn
ProMIS Neurosciences Announces Third Quarter 2024 Financial Results and Recent Highlights
Low
Report
ProMIS Neurosciences Announces Third Quarter 2024 Financial Results and Recent Highlights
11/12
07:28 am
pmn
ProMIS Neurosciences to Participate in Guggenheim’s Inaugural Healthcare Innovation Conference [Canadian Business Journal (Canada)]
Medium
Report
ProMIS Neurosciences to Participate in Guggenheim’s Inaugural Healthcare Innovation Conference [Canadian Business Journal (Canada)]
11/12
07:00 am
pmn
ProMIS Neurosciences to Participate in Guggenheim’s Inaugural Healthcare Innovation Conference
Medium
Report
ProMIS Neurosciences to Participate in Guggenheim’s Inaugural Healthcare Innovation Conference
10/30
08:09 am
pmn
ProMIS Neurosciences Presents Positive Data from PMN310 Phase1a Clinical Trial at the 17th Clinical Trials on Alzheimer's Disease Conference [Financial Post (Toronto, Ontario, Canada)]
Medium
Report
ProMIS Neurosciences Presents Positive Data from PMN310 Phase1a Clinical Trial at the 17th Clinical Trials on Alzheimer's Disease Conference [Financial Post (Toronto, Ontario, Canada)]
10/30
08:00 am
pmn
ProMIS Neurosciences Presents Positive Data from PMN310 Phase1a Clinical Trial at the 17th Clinical Trials on Alzheimer’s Disease Conference
Low
Report
ProMIS Neurosciences Presents Positive Data from PMN310 Phase1a Clinical Trial at the 17th Clinical Trials on Alzheimer’s Disease Conference
10/13
03:00 pm
pmn
ProMIS Neurosciences, Inc. (PMN): Analysts Are Bullish On This Undervalued Canadian Stock Now [Yahoo! Finance]
Low
Report
ProMIS Neurosciences, Inc. (PMN): Analysts Are Bullish On This Undervalued Canadian Stock Now [Yahoo! Finance]
9/12
07:09 am
pmn
ProMIS Neurosciences to Showcase PMN310's Ability to Target Toxic Oligomers and Distinguish from Other Amyloid-Beta Oligomers in Preclinical Studies at the 4th International Conference on Cognitive & Behavioral Neurosciences [Financial Post (Toronto, Ont
Medium
Report
ProMIS Neurosciences to Showcase PMN310's Ability to Target Toxic Oligomers and Distinguish from Other Amyloid-Beta Oligomers in Preclinical Studies at the 4th International Conference on Cognitive & Behavioral Neurosciences [Financial Post (Toronto, Ont
9/12
07:00 am
pmn
ProMIS Neurosciences to Showcase PMN310’s Ability to Target Toxic Oligomers and Distinguish from Other Amyloid-Beta Oligomers in Preclinical Studies at the 4th International Conference on Cognitive & Behavioral Neurosciences
Medium
Report
ProMIS Neurosciences to Showcase PMN310’s Ability to Target Toxic Oligomers and Distinguish from Other Amyloid-Beta Oligomers in Preclinical Studies at the 4th International Conference on Cognitive & Behavioral Neurosciences
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
11/20
07:04 pm
pmn
Form 4 ProMIS Neurosciences For: Nov 18 Filed by: Milbury Max A.
Low
Report
Form 4 ProMIS Neurosciences For: Nov 18 Filed by: Milbury Max A.
11/20
07:03 pm
pmn
Form 4 ProMIS Neurosciences For: Nov 18 Filed by: Kaplan Johanne
Low
Report
Form 4 ProMIS Neurosciences For: Nov 18 Filed by: Kaplan Johanne
11/20
07:02 pm
pmn
Form 4 ProMIS Neurosciences For: Nov 18 Filed by: Cashman Neil
Low
Report
Form 4 ProMIS Neurosciences For: Nov 18 Filed by: Cashman Neil
11/20
07:01 pm
pmn
Form 4 ProMIS Neurosciences For: Nov 18 Filed by: ALTSTIEL LARRY DOUGLAS
Low
Report
Form 4 ProMIS Neurosciences For: Nov 18 Filed by: ALTSTIEL LARRY DOUGLAS
11/14
04:56 pm
pmn
Form SC 13G/A ProMIS Neurosciences Filed by: GREAT POINT PARTNERS LLC
Low
Report
Form SC 13G/A ProMIS Neurosciences Filed by: GREAT POINT PARTNERS LLC
11/14
03:36 pm
pmn
Form SC 13G ProMIS Neurosciences Filed by: ARMISTICE CAPITAL, LLC
Low
Report
Form SC 13G ProMIS Neurosciences Filed by: ARMISTICE CAPITAL, LLC
11/14
09:30 am
pmn
Form 10-Q ProMIS Neurosciences For: Sep 30
Medium
Report
Form 10-Q ProMIS Neurosciences For: Sep 30
11/14
09:17 am
pmn
Form 8-K ProMIS Neurosciences For: Nov 14
Low
Report
Form 8-K ProMIS Neurosciences For: Nov 14
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: